The two MLL subtype patients (SJBALL021549_D1 and SJINF066_D) with GATA2 activation both carried the KMT2A-USP2 fusion, which is rare in B-ALL and its function has been largely unexplored. Here, KMT2A is linked to acute lymphoblastic leukemia.